Dr. Hamid Haroon Kadiwala, MD

Dr. Kadiwala practices at Tarrant Neurology Consultants, P.A. in Fort Worth, Texas.

Dr. Kadiwala's NPI, 1275768657, was assigned on May 28, 2009. Dr. Kadiwala graduated from UT Southwestern Medical Center in 2009. Dr. Kadiwala holds Texas license P7474.

Dr. Kadiwala's primary practice is Tarrant Neurology Consultants, P.A., at 713 Grainger St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 336-3968.

Dr. Kadiwala's primary practice is Tarrant Neurology Consultants, P.A. in Fort Worth, Texas. Dr. Kadiwala is also affiliated with Texas Health Fort Worth. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Kadiwala to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadiwala practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kadiwala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kadiwala is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kadiwala's licenses on file in 3 states: Texas, Pennsylvania and Ohio.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Kadiwala treats.

CMS data shows 1,354 Medicare services from Dr. Kadiwala across 10 procedure codes in 2024, for 495 Medicare patients. Medicare paid $144,685 for them.

CMS counts 495 Medicare patients who saw Dr. Kadiwala in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadiwala's median patient age at 56, with 56% women.

In 2024, Dr. Kadiwala wrote 4,527 Medicare Part D claims for 479 patients. 84% of them were for generic drugs. CMS names the drug for 4,260 of them, across 66 drugs with 11 or more claims each, at $1,657,019 in total drug cost. In 2023, CMS named 4,239 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kadiwala for performance year 2024, reported as part of a group. Dr. Kadiwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadiwala as offering telehealth.

CMS Open Payments shows 1,581 general payments to Dr. Kadiwala from 91 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Abbvie Inc. paid the most, $55,313.

Dr. Kadiwala graduated from UT Southwestern Medical Center in 2009.

Dr. Kadiwala is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.